• V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    Wednesday April 24th 2024

  • RheumaFinder announces investment by Novalis Biotech to revolutionize care for patients with rheumatic diseases

    Tuesday February 27th 2024

  • Altavo concludes Series A for the development of its Artificial Voice

    Tuesday February 20th 2024

  • Mithra sells shares in Mayne Pharma

    Thursday February 15th 2024

  • Protealis secures EUR 22 million in oversubscribed B-round funding to propel sustainable plant protein seed solutions

    Tuesday January 23rd 2024

  • Sequana Medical granted US CPT® III reimbursement codes for alfapump® system

    Wednesday January 3rd 2024

  • AstriVax awarded €3 million grant to advance therapeutic Hepatitis B vaccine

    Tuesday December 12th 2023

  • Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

    Wednesday November 22nd 2023

  • Your news here?

  • Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement

    Monday October 23rd 2023

  • Agomab raises $100 million Series C to advance fibrosis-focused pipeline

    Wednesday October 11th 2023

  • Agreement regarding recapitalization of operating subsidiaries by secured creditors and wind down of listed holding company

    Tuesday September 26th 2023

Strategic Partners